The dexamethasone-dependent overexpression of NNMT is likely relevant to tumor types other than glioblastoma, as suggested by a proteomic screen that identified “nicotinamide metabolism” as a process activated by GR in breast cancer cells (36). This evidence concerns the gene NR3C1 and neoplasm.